Volume 10, Number 1—January 2004
Dispatch
Adenovirus Type 7 Genomic-Type Variant, New York City, 1999
Jennifer Ann Marie Calder*
, Dean D. Erdman†, Joel Ackelsberg†‡1, Stephen William Cato*2, Vicki-Jo Deutsch†*, Anthony John Lechich*, and Barbara Susan Schofield*
, Dean D. Erdman†, Joel Ackelsberg†‡1, Stephen William Cato*2, Vicki-Jo Deutsch†*, Anthony John Lechich*, and Barbara Susan Schofield*
Table.a
| Clinical characteristic | Confirmed (N = 30) | Suspected (N = 12) |
|---|---|---|
| Female | 13 (43.3) | 5 (41.7) |
| Male | 17 (56.7) | 7 (58.3) |
| Mean age, in y | 9 | 12 |
| Median (range) | 6 (1–32) | 12 (1–25) |
| Fever >38.3°C | 30 (100.0) | 11 (91.7) |
| Increased tracheal secretions | 24 (80.0) | 10 (83.3) |
| Chest congestion | 23 (76.7) | 11 (91.7) |
| Tracheitis | 23 (76.7) | 9 (75.0) |
| Pneumonia | 18 (60.0) | 7 (58.3%) |
| Wheezing | 16 (53.3) | 5 (41.2) |
| Cough | 9 (30) | 4 (33.3) |
| Nasal congestion | 2 (6.7) | 0 |
| Runny nose | 1 (3.3) | 1 (8.3) |
aExcept for age, data are number of patients with the characteristic (%).
1Dr. Ackelsberg’s current affiliation is New York City Department of Health and Mental Hygiene, 125 Worth Street, Room 300, Box 22-A, New York, NY 10013, USA.
2Dr. Cato’s current affiliation is Aneese Realty Group, 741 East 42nd Street Lower Suite, Brooklyn, NY 11203, USA.
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.